GeneCradle

Beijing, China · Founded 2018 · Privately Held (backing)

Developer of gene therapy drugs intended to treat rare diseases. GeneCradle is based in Beijing, China and was founded in 2018. Its last reported valuation was $288 million in Feb 2022. It has raised $61 million.

Last reported valuation
$287.8M
Oct 2026
Priced at
—
Total raised
$61.0M
Last round
—

Who backs GeneCradle?

9 investors
InvestorType
Shenzhen Capital GroupVenture capital
Oriental Fortune CapitalVenture capital
YuanBio Venture CapitalVenture capital
CASH CapitalVenture capital
Cherami Investment GroupAsset manager
Saiying CapitalOther
Gandao Investment Holding Company—
Huajin Investment—
Yizhuang Guotou—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

GeneCradle investors

9 investors are on record for GeneCradle, including Shenzhen Capital Group, Oriental Fortune Capital, YuanBio Venture Capital and CASH Capital. By type, the record holds 4 venture capital firms and 1 asset manager.

Free account
More of GeneCradle with a free account
  • ·Watch GeneCradle: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like GeneCradle. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View